Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.34 | 18.82 |
| PEG Ratio (TTM) | 0.01 | -0.07 |
| P/S Ratio (TTM) | 0.26 | 0.55 |
| P/B Ratio (TTM) | 2.30 | 1.40 |
| P/FCF Ratio (TTM) | -1.59 | 13.50 |
| Price to 5YR AVG Earnings Ratio | N/A | 15.48 |
| Price to 5YR AVG FCF Ratio | N/A | 62.46 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -41.73% | 4.37% |
| ROE (TTM) | -98.21% | 9.38% |
| Net Profit Margin (TTM) | -77.05% | 1.13% |
| ROIC 5YR AVG | N/A | 12.07% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -33.43% | 24.39% | N/A |
| Revenue | -7.07% | -2.15% | N/A |
| Net Income | -36.99% | 17.60% | N/A |
| Cash Flow | -547.74% | -59.74% | N/A |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.85 | 1.99 |
| Quick Ratio (TTM) | 0.37 | 1.18 |
| D/E Ratio (TTM) | 0.05 | 0.52 |
| Interest Coverage (TTM) | -3.47 | 4.33 |
| Piotroski F-Score | 3 | 7 |
| Altman Z-Score | N/A | 3.93 |
| LTL to 5YR AVG FCF | N/A | 18.32 |
| Shares Outstanding Growth 5YR AVG | N/A | 0.90% |